Application 212555
- Type
- ANDA
- Sponsor
- GLENMARK PHARMS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | NINTEDANIB | NINTEDANIB ESYLATE | CAPSULE;ORAL | EQ 150MG BASE | No | No |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 68025 | ORIG | 2021-07-07 |